Komori
Governance4894Cuorips Inc.Pharmaceuticals

Independent Officer Notification Form

As proposals to elect 2 outside directors and 3 outside corporate auditors will be submitted to the annual general meeting of shareholders scheduled for 25 June 2026, 5 people have been reported as independent officers. Kato Yukihiro (加藤之啓) is a new appointee.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
5
independent officers
Wording
Definitive
How definitive the wording is.

Governance structure

Number of directors2 outside directors (total number of directors: Not disclosed)
Number of independent officers5Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

Proposals to elect 2 outside directors and 3 outside corporate auditors will be submitted to the annual general meeting of shareholders scheduled for 25 June 2026. Kato Yukihiro (加藤之啓) is a new appointee. All 5 people have been reported as independent officers.

Governance structure
ItemDetails
Number of directors2 outside directors (total number of directors: Not disclosed)
Number of independent officers5
Changes this timeProposals to elect 2 outside directors and 3 outside corporate auditors will be submitted to the annual general meeting of shareholders scheduled for 25 June 2026. Kato Yukihiro (加藤之啓) is a new appointee. All 5 people have been reported as independent officers.
Items this document does not state (5)
Corporate Governance StructureCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Proposals to elect 2 outside directors and 3 outside corporate auditors will be submitted to the annual general meeting of shareholders. Each candidate has been designated as an independent officer to oversee management by leveraging their professional experience and knowledge and to strengthen the protection of general shareholders’ interests.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Cuorips Inc. (4894) timely disclosure | Komori